Home/Filings/4/0000950170-25-102150
4//SEC Filing

Collard Craig A 4

Accession 0000950170-25-102150

CIK 0000818033other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 5:21 PM ET

Size

7.0 KB

Accession

0000950170-25-102150

Insider Transaction Report

Form 4
Period: 2025-07-31
Collard Craig A
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2025-07-3134,789487,042 total
    Exercise: $0.00Common Stock (34,789 underlying)
  • Exercise/Conversion

    Common Stock

    2025-07-31+34,789474,538 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).

Documents

1 file

Issuer

HERON THERAPEUTICS, INC. /DE/

CIK 0000818033

Entity typeother

Related Parties

1
  • filerCIK 0001363558

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 5:21 PM ET
Size
7.0 KB